| Literature DB >> 27846864 |
Guodao Wen1, Chao Tang1, Chunyu Zhong2, Junyang Li1, Zixiang Cong1, Yuan Zhou1, Kaidong Liu1, Yong Zhang3, Mamatemin Tohti4, Chiyuan Ma5.
Abstract
BACKGROUND: Binostril endoscopic transsphenoidal approach (BETA) provides sufficient manipulation space and wide endoscopic vision, although it increases the trauma of nose. Mononostril endoscopic transsphenoidal approach (META) has minimal trauma of nose, at the expense of space within the operation. We describe a one-and-a-half nostril endoscopic transsphenoidal approach (OETA) that combines the advantages of BETA and META.Entities:
Keywords: Endonasal endoscopic transsphenoidal approach; Manipulation space; One-and-a-half nostril; The “rescue” nasoseptal flap; Trauma of nose
Mesh:
Year: 2016 PMID: 27846864 PMCID: PMC5111234 DOI: 10.1186/s40463-016-0174-y
Source DB: PubMed Journal: J Otolaryngol Head Neck Surg ISSN: 1916-0208
Fig. 3Intraoperative endoscopic images. a Localisation of the sphenoid ostium at the sphenoethmoidalrecessus. b–d Creating the right “rescue” nasoseptal flap- from 2 to 3 mm below the sphenoid ostium to the intercutaneomucous point of the nasal vestibule. e The nasoseptal flap was gently folded in the floor of nasal cavity. f A vertical incision of the left nasal septal mucosa was made. g A sufficient binasal access for two-surgeons using the four-handed technique. h–i The binasal mucosa and turbinates were placed back in normal anatomic position. a = sphenoid sinus ostium; b = medial nasal septum; c = the bony nasal septum; d = the right middle nansal turbinate; e = the intercutaneomucous point of the nasal vestibule; f = the vertical incision of the left nasal septal mucosa; g = the left middle nansal turbinate; h = the sphenoid rostrum
Fig. 1Illustration of the one-and-a-half nostril endoscopic transsphenoidal approach. a Creating the right “rescue” nasoseptal flap. The blue line shows mucosal cutting line: from 2 to 3 mm below the sphenoid ostium to the intercutaneomucous point of the nasal vestibule. If anasoseptal flap is necessary, the yellow mucosal cutting line is made: along the floor of the nasal cavity from the choanae to the front of the first incision. b One-and-a-half approach: a vertical incision of the left nasal septal mucosa was made, which extended approximately 2 cm at the anterior-level of the middle turbinate. Binostril approach: a part of left posterior septal mucosa was necessarily resected
Fig. 2The difference between mononostril, one-and-a-half nostril and binostril approach. a Mononostril: a part of unilateral posterior septal mucosa was need incision and the contralateral mucosa was integral maintained; all surgical instruments manipulation only in a nasal cavitie. b One-and-a-half approach:the unilateral septal mucosa was required incising for a “rescue” nasoseptal flap, and the contralateral mucosa just needed approximately 2 cm incision; c Binostril approach: a part of bilateral posterior septal mucosa was necessarily resected. For one-and-a-half nostril and binostril approach, the assistant surgeon guided the endoscope through the right nostril while the senior surgeon manipulated the instruments through both nostrils
Patient demographics and tumor characteristics
| Patient age, mean ± SD, y | 49.7 ± 14.1 |
| Male/female, n | 35/22 |
| Follow up (range), mo | 18 (6–24) |
| Tumor with volumes mm3 | 22*20*20 |
| Recurrent, n (%) | 7 (12.3%) |
| Presenting symptoms, n (%) | |
| Abnormal visual functions | 32 (56%) |
| Endocrinopathy | 18 (32%) |
| Headache | 13 (23%) |
| Incidental | 7 (12%) |
| Pituitary apoplexy | 6 (11%) |
| Knosp score, n (%) | |
| 0 | 3 (5.3%) |
| 1 | 8 (14.0%) |
| 2 | 16 (28.1%) |
| 3 | 19 (33.3%) |
| 4 | 11 (19.3%) |
| Nonfunctioning adenoma, n (%) | 39 (68.4%) |
| Functioning adenoma, n (%) | 18 (31.6%) |
| Growth hormone | 12 (21.1%) |
| Prolactinomas | 4 (7.0%) |
| ACTH | 2 (3.5%) |
Outcomes of surgery
| Gross Total Resection, n (%) | |
| Overall | 45 (79%) |
| Knosp score | |
| 0 | 3 (100%) |
| 1 | 8 (100%) |
| 2 | 16 (100%) |
| 3 | 7 (63.6%) |
| 4 | 3 (27.3%) |
| Hormonal remission rate, n (%) | |
| Overall | 14 (77.8%) |
| Growth hormone | 10 (83.3%) |
| Prolactinomas | 3 (75%) |
| ACTH | 1 (50%) |
| Visual outcomes, n (%) | |
| Improved | 23 (72%) |
| Stable | 9 (28%) |
| Worse | 0 |
Complications
| Intraoperative cerebrospinal fluid leak | 10 (17.5%) |
| The use of unilateral “rescue” nasoseptal flap | 12 (21.1%) |
| Postoperative cerebrospinal fluid leak | 2 (3.5%) |
| Temporary diabetes insipidus | 3 (5.3%) |
| Anterior pituitary insufficiency | 3 (5.3%) |
| Epistaxis | 0 |
The main sinonasal complaints’ questionnaire
| Question 1: What are your main sinonasal complaints? | |
| Question 2: How do you feel about your sinonasal complaints? | |
| A. Worse than preoperation | B. Like preoperation |
The health status questionnaire
| How do you feel about your health status? | |
| A. Worse than preoperation | B. Like preoperation |
Sinonasal quality of life and health status (follow up = 50)
| Sinonasal complaints | Two weeks after surgery | Three months after surgery | Six months after surgery |
|---|---|---|---|
| Sense of smell damage | 14 (28%) | 2 (4%) | 0 |
| Sense of taste damage | 2 (4%) | 0 | 0 |
| Trouble breathing day | 9 (18%) | 1 (2%) | 1 (2%) |
| Thick nasal discharge | 18 (36%) | 5 (10%) | 0 |
| Post nasal discharge | 4 (8%) | 0 | 0 |
| Dried nasal material | 3 (6%) | 0 | 0 |
| Headache | 3 (6%) | 1 (2%) | 1 (2%) |
| No sinonasal discomfort | 1 (2%) | 41 (82%) | 48 (96%) |
| Health status | |||
| Recovering to preoperative status | 0 | 15 (30%) | 48 (96%) |
Fig. 4Postoperative outpatient follow-up after 3 months after surgery demonstrating the nasal mucosa favorable recovery and well prognosis. a the right nasal cavity, the arrow shows the right “rescue” nasoseptal flap interface. b the left nasal cavity, the arrow shows the interface of incision of the left nasal septal mucosa nasal. c The bottom of the saddle mucosa healed completely
Relevant parameters in this paper compared with those in the literature
| Authors & Year | Cases | App | GTR | Complications | ||||
|---|---|---|---|---|---|---|---|---|
| Knosp 0–2 | Knosp 3–4 | Csf | Tdi | Api | Ep | |||
| Cappabianca. P. et al. 2002 [ | 146 | uni | 62.3% | 2% | 5.5% | 13.7% | 1.4% | |
| Rudnik, A. et al. 2007 [ | 70 | uni | 87.3% | 6.7% | 2.8% | 5.4% | 11.4% | 1.4% |
| Zhang, Y. et al. 2008 [ | 678 | uni | 80.15 | 2.1% | / | / | 0.3% | |
| Bodhinayake, I. et al. 2014 [ | 64 | uni | 68.7% | 4.1% | 3.1% | 4.7% | / | |
| Bokhari, A. R. et al. 2013 [ | 79 | bi | 63% | 3% | 10% | / | / | |
| López Arbolay, O. et al. 2013 [ | 278 | bi | 92.4% | 1.4% | 3.9% | 3.6% | / | |
| Paluzzi, A. et al. 2014 [ | 555 | bi | 67.1% | 5% | / | 2.9% | 1.1% | |
| Dallapiazza, RF.et al. 2015 [ | 80 | bi | 93.5% | 28% | 2.5% | / | / | 1.3% |
| Present study | 57 | oeta | 100% | 33.3% | 3.5% | 5.3% | 5.3% | 0 |
App approach, GTR gross total resection, Csf cerebrospinal fluid leak; Tdi Temporary diabetes insipidus, Api Anterior pituitary insufficiency, Ep Epistaxis, uni unilateral, bi bilateral, oeta one and a half endoscopic transsphenoidal approach